Advancing transmural remission as a treatment target in Crohn's disease: The future of tight‐control strategy?
Ferdinando D'Amico, Sara Massironi, Mariangela Allocca, Silvio Danese · 2023
Read Advancing transmural remission as a treatment target in Crohn's disease: The future of tight‐control strategy? by Ferdinando D'Amico, Sara Massironi, Mariangela Allocca, Silvio Danese (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10720679.txt.
Description
Ferdinando D'Amico and co-authors argue for a deeper treatment target in Crohn's disease in a 2023 review. Crohn's damages the full bowel wall, not just its lining. Goals have already moved from symptom relief to healing of the lining seen on scope exams. The authors push one step further: transmural remission, healing through the whole wall, judged by bowel ultrasound or MRI.
An expert group has proposed a working definition based on wall thickness and blood flow signals. Reaching that state is hard: at best half of patients get there, even on advanced drugs. A recent study they discuss used a tight-control strategy, watching a stool marker and raising treatment when it stirred. That approach lifted transmural remission rates, most of all in early disease. The authors present tight control as the future path. They call for shared definitions and trials to settle the target.
Catalog record
| CREATOR | Ferdinando D'Amico, Sara Massironi, Mariangela Allocca, Silvio Danese |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |